APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Peptide Industry Growth and Trends Forecast to 2032

31 December 2025108 pages

Choose your research edition.

Industry ResearchTherapeutic Peptide Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Peptide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Therapeutic Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Peptide Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Peptide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Therapeutic Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Peptide include Takeda, Teva, Sanofi, Johnson and Johnson, Novartis, Novo Nordisk, Merck, Eli Lilly and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Peptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Peptide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Peptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Peptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Therapeutic Peptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Peptide Market by Company

Takeda

Teva

Sanofi

Johnson and Johnson

Novartis

Novo Nordisk

Merck

Eli Lilly

AbbVie

AstraZeneca

Ipsen

Therapeutic Peptide Segment by Type

Oral

Injection

Other

Therapeutic Peptide Segment by Application

Central Nervous System

Metabolic Disorders

Cancer

Other

Therapeutic Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Therapeutic Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Major Company of Other Table 4. Global Therapeutic Peptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 6. Global Therapeutic Peptide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Therapeutic Peptide Sales Market Share in Value by Type (2021-2026) Table 9. Global Therapeutic Peptide Price by Type (2021-2026) & (US$/Unit) Table 10. Global Therapeutic Peptide Sales by Type (2027-2032) & (K Units) Table 11. Global Therapeutic Peptide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Therapeutic Peptide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Therapeutic Peptide Sales Market Share in Value by Type (2027-2032) Table 14. Global Therapeutic Peptide Price by Type (2027-2032) & (US$/Unit) Table 15. North America Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 16. North America Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 18. Europe Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 22. Latin America Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Therapeutic Peptide Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Therapeutic Peptide Sales by Type (2021-2026) & (US$ Million) Table 25. Therapeutic Peptide Industry Trends Table 26. Therapeutic Peptide Industry Drivers Table 27. Therapeutic Peptide Industry Opportunities and Challenges Table 28. Therapeutic Peptide Industry Restraints Table 29. Global Therapeutic Peptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Therapeutic Peptide Revenue Market Share by Company (2021-2026) Table 31. Global Therapeutic Peptide Sales by Company (2021-2026) & (K Units) Table 32. Global Therapeutic Peptide Sales Share by Company (2021-2026) Table 33. Global Therapeutic Peptide Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Therapeutic Peptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Therapeutic Peptide Major Company Production Sites and Headquarters Table 36. Global Therapeutic Peptide Company, Product Type & Application Table 37. Global Therapeutic Peptide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Therapeutic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Therapeutic Peptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Therapeutic Peptide Sales by Region (2021-2026) & (K Units) Table 42. Global Therapeutic Peptide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Therapeutic Peptide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Therapeutic Peptide Sales Market Share in Value by Region (2021-2026) Table 45. Global Therapeutic Peptide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Therapeutic Peptide Sales by Region (2027-2032) & (K Units) Table 47. Global Therapeutic Peptide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Therapeutic Peptide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Therapeutic Peptide Sales Market Share in Value by Region (2027-2032) Table 50. Global Therapeutic Peptide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Therapeutic Peptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 53. Global Therapeutic Peptide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Therapeutic Peptide Sales Market Share in Value by Application (2021-2026) Table 56. Global Therapeutic Peptide Price by Application (2021-2026) & (US$/Unit) Table 57. Global Therapeutic Peptide Sales by Application (2027-2032) & (K Units) Table 58. Global Therapeutic Peptide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Therapeutic Peptide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Therapeutic Peptide Sales Market Share in Value by Application (2027-2032) Table 61. Global Therapeutic Peptide Price by Application (2027-2032) & (US$/Unit) Table 62. North America Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 63. North America Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 65. Europe Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 69. Latin America Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Therapeutic Peptide Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Therapeutic Peptide Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda Therapeutic Peptide Product Portfolio Table 76. Takeda Recent Development Table 77. Teva Company Information Table 78. Teva Business Overview Table 79. Teva Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva Therapeutic Peptide Product Portfolio Table 81. Teva Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sanofi Therapeutic Peptide Product Portfolio Table 86. Sanofi Recent Development Table 87. Johnson and Johnson Company Information Table 88. Johnson and Johnson Business Overview Table 89. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Johnson and Johnson Therapeutic Peptide Product Portfolio Table 91. Johnson and Johnson Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis Therapeutic Peptide Product Portfolio Table 96. Novartis Recent Development Table 97. Novo Nordisk Company Information Table 98. Novo Nordisk Business Overview Table 99. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novo Nordisk Therapeutic Peptide Product Portfolio Table 101. Novo Nordisk Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merck Therapeutic Peptide Product Portfolio Table 106. Merck Recent Development Table 107. Eli Lilly Company Information Table 108. Eli Lilly Business Overview Table 109. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly Therapeutic Peptide Product Portfolio Table 111. Eli Lilly Recent Development Table 112. AbbVie Company Information Table 113. AbbVie Business Overview Table 114. AbbVie Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. AbbVie Therapeutic Peptide Product Portfolio Table 116. AbbVie Recent Development Table 117. AstraZeneca Company Information Table 118. AstraZeneca Business Overview Table 119. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AstraZeneca Therapeutic Peptide Product Portfolio Table 121. AstraZeneca Recent Development Table 122. Ipsen Company Information Table 123. Ipsen Business Overview Table 124. Ipsen Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Ipsen Therapeutic Peptide Product Portfolio Table 126. Ipsen Recent Development Table 127. North America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Therapeutic Peptide Sales by Country (2021-2026) & (K Units) Table 129. North America Therapeutic Peptide Sales Market Share by Country (2021-2026) Table 130. North America Therapeutic Peptide Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Therapeutic Peptide Sales Market Share Forecast by Country (2027-2032) Table 132. North America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Therapeutic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Therapeutic Peptide Market Share by Country (2021-2026) Table 135. North America Therapeutic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Therapeutic Peptide Market Share Forecast by Country (2027-2032) Table 137. Europe Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Therapeutic Peptide Sales by Country (2021-2026) & (K Units) Table 139. Europe Therapeutic Peptide Sales Market Share by Country (2021-2026) Table 140. Europe Therapeutic Peptide Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Therapeutic Peptide Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Therapeutic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Therapeutic Peptide Market Share by Country (2021-2026) Table 145. Europe Therapeutic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Therapeutic Peptide Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Therapeutic Peptide Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Therapeutic Peptide Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Therapeutic Peptide Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Therapeutic Peptide Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Therapeutic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Therapeutic Peptide Market Share by Country (2021-2026) Table 155. Asia-Pacific Therapeutic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Therapeutic Peptide Market Share Forecast by Country (2027-2032) Table 157. Latin America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Therapeutic Peptide Sales by Country (2021-2026) & (K Units) Table 159. Latin America Therapeutic Peptide Sales Market Share by Country (2021-2026) Table 160. Latin America Therapeutic Peptide Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Therapeutic Peptide Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Therapeutic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Therapeutic Peptide Market Share by Country (2021-2026) Table 165. Latin America Therapeutic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Therapeutic Peptide Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Therapeutic Peptide Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Therapeutic Peptide Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Therapeutic Peptide Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Therapeutic Peptide Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Therapeutic Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Therapeutic Peptide Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Therapeutic Peptide Market Share by Country (2021-2026) Table 175. Middle East and Africa Therapeutic Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Therapeutic Peptide Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Therapeutic Peptide Distributors List Table 180. Therapeutic Peptide Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Therapeutic Peptide Image Figure 2. Global Therapeutic Peptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Peptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Peptide Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Therapeutic Peptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Therapeutic Peptide Market Share by Type 2025 VS 2032 Figure 13. North America Therapeutic Peptide Sales Market Share in Volume by Type in 2025 Figure 14. North America Therapeutic Peptide Sales Market Share in Value by Type in 2025 Figure 15. Europe Therapeutic Peptide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Therapeutic Peptide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Therapeutic Peptide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Therapeutic Peptide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Therapeutic Peptide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Therapeutic Peptide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Central Nervous System Image Figure 26. Global Central Nervous System Sales YoY Growth (2021-2032) & (K Units) Figure 27. Metabolic Disorders Image Figure 28. Global Metabolic Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 29. Cancer Image Figure 30. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Therapeutic Peptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Therapeutic Peptide Market Share by Application 2025 VS 2032 Figure 35. North America Therapeutic Peptide Sales Market Share in Volume by Application in 2025 Figure 36. North America Therapeutic Peptide Sales Market Share in Value by Application in 2025 Figure 37. Europe Therapeutic Peptide Sales Market Share in Volume by Application in 2025 Figure 38. Europe Therapeutic Peptide Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Application in 2025 Figure 41. Latin America Therapeutic Peptide Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Therapeutic Peptide Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Therapeutic Peptide Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Application in 2025 Figure 45. North America Therapeutic Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Therapeutic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Therapeutic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Therapeutic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Therapeutic Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Therapeutic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Therapeutic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Therapeutic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Therapeutic Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Therapeutic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Therapeutic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Therapeutic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Therapeutic Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Therapeutic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Therapeutic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Therapeutic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Therapeutic Peptide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Therapeutic Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Therapeutic Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Therapeutic Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Therapeutic Peptide Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Therapeutic Peptide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
  • Other
Applications
  • Central Nervous System
  • Metabolic Disorders
  • Cancer
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • AbbVie
  • AstraZeneca
  • Ipsen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Peptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Therapeutic Peptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Therapeutic Peptide Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.3.3 Other
  9. 1.4 Global Therapeutic Peptide Market Size by Type
  10. 1.4.1 Global Therapeutic Peptide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Therapeutic Peptide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Therapeutic Peptide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Therapeutic Peptide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Therapeutic Peptide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Therapeutic Peptide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Therapeutic Peptide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Therapeutic Peptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Therapeutic Peptide Industry Trends
  2. 2.2 Therapeutic Peptide Industry Drivers
  3. 2.3 Therapeutic Peptide Industry Opportunities and Challenges
  4. 2.4 Therapeutic Peptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Therapeutic Peptide Revenue (2021-2026)
  2. 3.2 Global Top Players by Therapeutic Peptide Sales (2021-2026)
  3. 3.3 Global Top Players by Therapeutic Peptide Price (2021-2026)
  4. 3.4 Global Therapeutic Peptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Peptide Major Company Production Sites & Headquarters
  6. 3.6 Global Therapeutic Peptide Company, Product Type & Application
  7. 3.7 Global Therapeutic Peptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Peptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Peptide Tier 1, Tier 2, and Tier 3
4 Therapeutic Peptide Regional Status and Outlook
  1. 4.1 Global Therapeutic Peptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Therapeutic Peptide Historic Market Size by Region
  3. 4.2.1 Global Therapeutic Peptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Therapeutic Peptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Therapeutic Peptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Therapeutic Peptide Forecasted Market Size by Region
  7. 4.3.1 Global Therapeutic Peptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Therapeutic Peptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Therapeutic Peptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Therapeutic Peptide by Application
  1. 5.1 Therapeutic Peptide Market by Application
  2. 5.1.1 Central Nervous System
  3. 5.1.2 Metabolic Disorders
  4. 5.1.3 Cancer
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Peptide Market Size by Application
  7. 5.2.1 Global Therapeutic Peptide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Therapeutic Peptide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Therapeutic Peptide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Therapeutic Peptide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Therapeutic Peptide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Therapeutic Peptide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Therapeutic Peptide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Therapeutic Peptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Therapeutic Peptide Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Therapeutic Peptide Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Therapeutic Peptide Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson and Johnson
  20. 6.4.1 Johnson and Johnson Company Information
  21. 6.4.2 Johnson and Johnson Business Overview
  22. 6.4.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson and Johnson Therapeutic Peptide Product Portfolio
  24. 6.4.5 Johnson and Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Therapeutic Peptide Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Novo Nordisk
  32. 6.6.1 Novo Nordisk Company Information
  33. 6.6.2 Novo Nordisk Business Overview
  34. 6.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novo Nordisk Therapeutic Peptide Product Portfolio
  36. 6.6.5 Novo Nordisk Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck Therapeutic Peptide Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Therapeutic Peptide Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 AbbVie
  50. 6.9.1 AbbVie Company Information
  51. 6.9.2 AbbVie Business Overview
  52. 6.9.3 AbbVie Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AbbVie Therapeutic Peptide Product Portfolio
  54. 6.9.5 AbbVie Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Therapeutic Peptide Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Ipsen
  62. 6.11.1 Ipsen Company Information
  63. 6.11.2 Ipsen Business Overview
  64. 6.11.3 Ipsen Therapeutic Peptide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ipsen Therapeutic Peptide Product Portfolio
  66. 6.11.5 Ipsen Recent Developments
7 North America by Country
  1. 7.1 North America Therapeutic Peptide Sales by Country
  2. 7.1.1 North America Therapeutic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Therapeutic Peptide Sales by Country (2021-2026)
  4. 7.1.3 North America Therapeutic Peptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Therapeutic Peptide Market Size by Country
  6. 7.2.1 North America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Therapeutic Peptide Market Size by Country (2021-2026)
  8. 7.2.3 North America Therapeutic Peptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Therapeutic Peptide Sales by Country
  2. 8.1.1 Europe Therapeutic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Therapeutic Peptide Sales by Country (2021-2026)
  4. 8.1.3 Europe Therapeutic Peptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Therapeutic Peptide Market Size by Country
  6. 8.2.1 Europe Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Therapeutic Peptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Therapeutic Peptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Therapeutic Peptide Sales by Country
  2. 9.1.1 Asia-Pacific Therapeutic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Therapeutic Peptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Therapeutic Peptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Therapeutic Peptide Market Size by Country
  6. 9.2.1 Asia-Pacific Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Therapeutic Peptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Therapeutic Peptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Therapeutic Peptide Sales by Country
  2. 10.1.1 South America Therapeutic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Therapeutic Peptide Sales by Country (2021-2026)
  4. 10.1.3 South America Therapeutic Peptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Therapeutic Peptide Market Size by Country
  6. 10.2.1 South America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Therapeutic Peptide Market Size by Country (2021-2026)
  8. 10.2.3 South America Therapeutic Peptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Therapeutic Peptide Sales by Country
  2. 11.1.1 Middle East and Africa Therapeutic Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Therapeutic Peptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Therapeutic Peptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Therapeutic Peptide Market Size by Country
  6. 11.2.1 Middle East and Africa Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Therapeutic Peptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Therapeutic Peptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Therapeutic Peptide Value Chain Analysis
  2. 12.1.1 Therapeutic Peptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Therapeutic Peptide Production Mode & Process
  7. 12.2 Therapeutic Peptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Therapeutic Peptide Distributors
  10. 12.2.3 Therapeutic Peptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst